Advances in the Treatment of Renal Cell Carcinoma
| Advances in the Treatment of Renal Cell Carcinoma |
| Autore | Reynolds Paul |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (221 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
artesunate (ART)
autophagy biomarker biomarkers ccRCC chloroquine clear cell renal cell carcinoma cysteine cathepsin inhibitors cysteine cathepsins evolution evolutionary trajectory ferroptosis genomic signature growth inhibition hydroxychloroquine immune checkpoint inhibitors immune-based combination therapies immunotherapy individualization kidney cancer lysosome metastatic metastatic renal cell carcinoma mRCC network meta-analysis PD-L1 predictive RCC reactive oxygen species (ROS) renal cancer renal cell cancer renal cell carcinoma renal cell carcinoma (RCC) ROC-325 second line therapy soluble factors sunitib resistance TKIs Traditional Chinese Medicine (TCM) transcriptomic analysis treatment tyrosine kinase inhibitors |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557615503321 |
Reynolds Paul
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer Biomarker Research and Personalized Medicine
| Cancer Biomarker Research and Personalized Medicine |
| Autore | Meehan James |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (428 p.) |
| Soggetto topico |
Medicine and Nursing
Oncology |
| Soggetto non controllato |
1H-NMR
Akt/mTOR AmpliSeq anastomotic leak autophagy bioinformatics biomarker biomarkers bladder tumor breast cancer cancer biomarkers cancer vaccine chemoradiotherapy chemoresistance chemotherapy circulating tumor cells clear cell renal cell carcinoma colorectal cancer comparative oncology CREB1 cytokine signalling DNA methylation drug perturbation epigenetics exosomes FOXO3 gastric cancer GBP5 glycopeptide gp130 haptoglobin head and neck cancer head and neck squamous cell carcinoma hepatocellular carcinoma HNSCC hormone-dependent carcinogenesis HPV genotyping IL13Rα2 IL6ST immune response intestinal anastomosis JAK2 LC-MS/MS lincRNA-p21 lipidomics lipoprotein lipase lipoprotein subfractions liquid biopsy liquid-based biomarkers localized prostate cancer long non-coding RNA lymph node metastasis lymphocyte-to-monocyte ratio mass spectrometry meta-analysis microRNA middle-up-down multiphasic multidetector computed tomography n/a One Health ovarian cancer p16 expression p53 peripheral blood parameters personalized medicine precision medicine predictive biomarker predictive tools prognostic factors prognostic tools prostate cancer radiomics radioresistance radiosensitivity biomarkers radiotherapy rectal cancer renal cell carcinoma saliva secretome taxane telmisartan tissue-based biomarkers translational research transurethral resection triple-negative breast cancer tumor recurrence WHO/ISUP nuclear grade |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910674370003321 |
Meehan James
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Metastatic Progression and Tumour Heterogeneity
| Metastatic Progression and Tumour Heterogeneity |
| Autore | Hollande Fred |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (312 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
3D cultures
acidosis ADH angiocrine factor beta-catenin paradox biomechanics breast cancer carbonic anhydrase cell fate cellular heterogeneity circulating tumor cells circulating tumor cells (CTCs) clear cell renal cell carcinoma clonality collective and single-cell migration colon cancer colorectal cancer CTC-clusters DCIS deficient mismatch repair EMT endometrial carcinoma epigenetics epithelial mesenchymal plasticity epithelial-to-mesenchymal transition esophageal squamous cell carcinoma extracellular vesicles gene expression genomics heterogeneity hybrid E/M hyperpolarized 13C MRI immune checkpoints immune microenvironment immunotherapy interstitial pH intra-tumour heterogeneity intratumor heterogeneity lactic acid magnetic resonance imaging mammary gland metaplastic carcinoma metastasis metastatic niche microsatellite instability miRNA expression multisite tumor sampling mutation natural killer cells nuclear medicine organoids pancreatic cancer PET phenotypic plasticity PI3K/AKT pathway plasticity positron emission tomography precision medicine radiomics radiopharmaceuticals review signaling single-cell analysis single-cell RNAseq subclonal diversity SUV target discovery targeted therapy TP53 treatment resistance tumor ecology tumor endothelial cell tumor evolution tumor heterogeneity tumor microenvironment tumor mutation burden uterine carcinosarcoma Wnt signaling |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557105803321 |
Hollande Fred
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pleiotropic Action of Selenium in the Prevention and Treatment of Cancer, and Related Diseases
| Pleiotropic Action of Selenium in the Prevention and Treatment of Cancer, and Related Diseases |
| Autore | Rustum Youcef M |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 online resource (166 p.) |
| Soggetto topico | Biology, life sciences |
| Soggetto non controllato |
anticancer
anticancer agent antitumor activity apoptosis cancer cancer stem cells cell plasticity chemotherapeutics clear cell renal cell carcinoma clear-cell renal cell carcinoma microRNAs disease DNA damage DNA damage and repair EMT entosis epigenetics ER stress glutathione head and neck cancer HIF hSP56 hypoxia hypoxia-inducible factor hypoxia-inducible factors (HIFs) immune evasion isoselenourea lipid peroxidation malignant melanoma methylseleninic acid methylselenocysteine methylselenoesters miRNA mTOR inhibitors PD-L1 radiation SBP1 Se-containing nanoparticles SELENBP1 selenium selenium species selenium-binding protein 1 seleno-l-methionine STAT3 tocopherol tumor heterogeneity tumor microenvironment VEGF viability |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910346851003321 |
Rustum Youcef M
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Renal Cell Carcinoma
| Renal Cell Carcinoma |
| Autore | López José I |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (500 p.) |
| Soggetto topico | Biology, life sciences |
| Soggetto non controllato |
11) translocation renal cell carcinoma
ALK AMP-activated protein kinases anaplastic lymphoma kinase rearrangement aurora A biomarker cancer immunotherapy cancer-specific survival CDKN1A expression checkpoint inhibitors chromophobe renal cell carcinoma chromosomal loss chronic kidney disease circular RNAs in a clinico-genomic predictive model clear cell renal cell carcinoma clear cell Renal Cell Carcinoma collecting duct carcinoma copy number alteration copy number analysis copy number loss curcumin cytoreductive nephrectomy diagnostic and prognostic markers drug sensitivity efficacy emerging entity EMT like eosinophilic variant ESC everolimus EVI1 experimental validation of circular RNA FISH FOXO3 gene expression gene signature genetic association ghrelin glutathione metabolism glutathione transferase omega 1 glutathione transferase omega 2 glycomarkers glycoproteomics HOT hyperosmolality identification of circular RNAs IL-1? IL-2 IL13R?1 IL4R? immune checkpoint inhibitors immune infiltration immunohistochemistry immunotherapy inflammation markers integrins intratumour heterogeneity invasion JAK2 kidney kidney cancer label-free LOT metabolic reprogramming metabolome metabolome profiling metastasis metastatic ccRCC microRNA miR-133b miR-146a-5p miR-155-5p MiT family translocation renal cell carcinoma MMP-9 MMP10 molecular genetic features MTA2 mTOR mTOR inhibitors mutation N-glycomapping n/a nephrectomy new entity NK cells oncocytic renal tumor overall survival pale cell Papillary renal cell carcinoma (pRCC) patient survival PBRM1 PD-L1 pentose phosphate pathway PI3K/Akt/mTOR polybromo-1 polymorphism PPP practical approach predictive factors predictive role pro-IL-1? prognosis prognostic factors programmed death-ligand 1 proliferation proteome profiling Raf/MEK/ERK RCC recurrence free survival recurrence-free survival renal cancer renal cell renal cell cancer renal cell carcinoma review RNA sequencing sarcomatoid SMAD proteins solute carrier proteins statins survival survival prediction t(6 targeted therapy TCA cycle TCGA TFE3 TFEB TFEB-amplified renal cell carcinoma toxicity transforming growth factor beta tumor adhesion tumor microenvironment tumor migration tumor slice culture tyrosine kinase inhibitors unclassified renal cell carcinoma unclassified renal tumor uric acid urine VEGF inhibitors von Hippel-Lindau Xp11 translocation renal cell carcinoma |
| ISBN | 3-03928-639-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910404087003321 |
López José I
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||